UK-based pharmaceutical group AstraZeneca today announced its Q1 2018 results, before trading started in Europe. Investors did not approve the performance and AstraZeneca’s shares soon declined 2.3% as trading started.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,